| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702614 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
This commentary discusses and evaluates the clinical experience with nivolumab from the available literature and presents practical considerations for the use of nivolumab immunotherapy in aRCC to optimize clinical management.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Richard W. M.D., Gurkamal M.D., Ulka M.D.,